TP53 and hepatocellular carcinoma: Recombinant human adenovirus ASPP2 is also found to play a synergistic inhibitory effect on hepatocellular carcinoma formation by influencing protein expression associated with proliferation, apoptosis, autophagy and vascular growth via a p53‐independent pathway in vivo.32